PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Visit https://www.peervoice.com/GYQ860 to view the entire programme with slides. After completing “Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure”, participants will be able to: Evaluate the impact of hyperkalaemia and its implications for cardiovascular and renal protection and disease management; Apply current evidence and guidance for the use of potassium binders to enable optimisation of recommended therapies, such as renin angiotensin aldosterone system inhibition (RAASi), in patients at risk for and with heart failure (HF) and/or chronic kidney disease (CKD); and Design practical strategies for the long-term management of chronic hyperkalaemia which optimise safety, efficacy, quality of life, and overall patient outcomes.